WO1999006581A1 - Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures - Google Patents

Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures Download PDF

Info

Publication number
WO1999006581A1
WO1999006581A1 PCT/US1998/016033 US9816033W WO9906581A1 WO 1999006581 A1 WO1999006581 A1 WO 1999006581A1 US 9816033 W US9816033 W US 9816033W WO 9906581 A1 WO9906581 A1 WO 9906581A1
Authority
WO
WIPO (PCT)
Prior art keywords
tryptamine
tdc
plant tissue
gene
nucleic acid
Prior art date
Application number
PCT/US1998/016033
Other languages
English (en)
Inventor
John Sanford
Alan D. Blowers
Franzine Smith
Joyce Van Eck
Original Assignee
Sanford Scientific, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Scientific, Inc. filed Critical Sanford Scientific, Inc.
Priority to JP2000505321A priority Critical patent/JP2001512028A/ja
Priority to EP98938251A priority patent/EP0994957A1/fr
Priority to CA002298882A priority patent/CA2298882A1/fr
Priority to AU86821/98A priority patent/AU8682198A/en
Publication of WO1999006581A1 publication Critical patent/WO1999006581A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8285—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for nematode resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the present invention relates to transgenic plants having surprisingly improved fungal, bacterial, and/or nematode disease resistance, wherein the enhanced resistance arises from enhanced expression of a tryptophan decarboxylase (TDC) gene.
  • TDC tryptophan decarboxylase
  • defensins Other antimicrobial peptides, termed defensins (for review, see Broekaert et al. (1995) Plant Physiol. 108, 1353-1358) have been isolated from radish (Terras et al. (1992) J. Biol. Chem. 267, 15301-15309) and barley (Mendenez et al. (1990) Eur. J. Biochem. 194, 533-539) and feature a more complex three-dimensional structure that includes cysteine-stabilized triple anti-parallel ⁇ sheets together with an ⁇ -helix. Terras et al.
  • ribosome-inactivating proteins which act by inhibiting protein synthesis in target cells by a modification of the 28S rRNA.
  • RLP's do not affect the ribosomes of the plants in which they are produced, but can be effective against fungal ribosomes.
  • a barley RIP under control of a wound-inducible promoter was reported to show increased resistance to Rhizoctonia solani (Logemann et al. (1992) Biotech 10, 305-308). Finally, Alexander et al. (1993) ProcNatl. Acad.
  • Plants produce a rich diversity of secondary metabolites, which do not seem necessary for their basic metabolism, but appear to contribute to their environmental fitness and adaptability. These secondary compounds are responsible for aroma (monote ⁇ ene indole alkaloids) and color (anthocyanins and carotenoids) and are commercial sources of numerous important pharmaceutical (alkaloids) and industrial chemicals. Their importance has encouraged intensive investigation of the regulation and control of the biosynthetic pathways, and more recently, how these pathways can be manipulated through "metabolic engineering,” first coined by Bailey, J.E. (1991) Science 251, 1668- 1675, as "the improvement of cellular activities by manipulation of enzymatic, transport, and regulatory functions of the cell with the use of recombinant DNA technology.”
  • the enzymology associated with the biosynthesis of alkaloids has been the subject of much study.
  • the tropical plant, Catharanthus roseus (periwinkle) forms a wide range of te ⁇ enoid indole alkaloids (TIA's), some of which have important medicinal applications.
  • TIA's te ⁇ enoid indole alkaloids
  • the leaf-derived alkaloids, vinblastine and vincristine, and the root-derived alkaloids, ajmalicine and se ⁇ entine are valuable drugs for treatment of cardiac/circulatory diseases and tumors, respectively. It is generally accepted that protoalkaloid production is the first committed step in the TIA pathway of Catharanthus.
  • tryptophan decarboxylase the enzyme that catalyzes this bridge reaction between primary (amino acid) and secondary (alkaloid) metabolic pathways, has drawn much attention.
  • TDC catalyzes the decarboxylation and conversion of L-tryptophan into tryptamine. Tryptamine and horrin, another secondary compound, are then condensed to form strictosidine, the precursor for all TIA's in Catharanthus.
  • anthranilate synthase a heterodimeric enzyme composed of an ⁇ and ⁇ subunit, which catalyzes the conversion of chorismate to anthranilate. Tryptophan has been demonstrated to be a negative feedback regulator of the microbial enzyme. In microbes, when tryptophan levels are sufficiently high, tryptophan binds to an allosteric site on the ⁇ subunit, thereby inactivating the enzyme. Although similar observations have not been made for the plant enzyme, other studies suggest that AS is the rate-limiting enzyme for tryptophan biosynthesis. Plant mutants characterized by elevated tryptophan levels ( ⁇ 3-fold) have been found to contain amino acid changes in their anthranilate synthase coding regions.
  • TDC steady-state transcript levels were most abundant in roots, moderately abundant in leaves and barely detectable in the flowers and stems of 3-month-old Catharanthus plants. They further demonstrated that TDC expression in cell suspension cultures was down-regulated by addition of auxin, but strongly induced by treatment with fungal elicitors. This report, along with others (Roewer et al. (1992) Plant Cell Rep. 11, 86-89; Berlin et al. (1993) Transgenic Res. 2, 336-3444; Goddijn et al. (1992) Plant Mol. Biol. 18, 1113-1120; and Goddijn et al. (1995) Transgenic Res. 4, 315-323), helped establish the importance of TDC as the first committed step in TIA biosynthesis.
  • transgenic canola In contrast to tobacco, transgenic canola, which overexpressed the same TDC transgene, exhibited a very striking phenotype. Chavadej et al. (1994) Proc. Natl. Acad. USA 91, 2166-2170, reported that their best transgenic canola line never expressed >9% of the TDC-specific activity and only accumulated 2% of the tryptamine found in the most active transgenic tobacco line.
  • tryptamine accumulation was found to be very tissue specific (Yao et al. (1995) Plant Cell 7, 1787- 1799). While tryptamine accumulated to high levels in the leaves of transgenic potato plants, tryptamine was undetectable in the tubers and was only detected after wounding or fungal elicitor treatment. The re-direction of tryptophan into tryptamine resulted in a dramatic decrease in the levels of soluble tryptophan, phenylalanine, and phenylalanine derived phenolic compounds, including chlorogenic acid, the major soluble phenolic ester in potato tubers.
  • tryptamine can effectively inhibit in vitro and in vivo growth of both phytopathogenic bacteria and fungi. Furthermore, tryptamine is shown herein to inhibit phytopathogenic nematodes.
  • the present invention affords constitutive expression in plants of the gene encoding tryptophan decarboxylase (TDC), the enzyme that converts tryptophan to tryptamine, to confer enhanced resistance to infection to a broad spectrum of phytopathogenic fungi, bacteria, and nematodes.
  • TDC tryptophan decarboxylase
  • AS gene can boost this pathway, making more ty ⁇ tamine.
  • the present invention further provides a gene construct containing a promoter and a DNA sequence encoding a protein with tryptophan decarboxylase activity and/or AS activity.
  • the invention also provides transgenic plants and multicellular plant tissue having enhanced fungal and/or bacterial disease resistance and/or nematode resistance, wherein the enhanced resistance is a result of expression of a TDC and/or AS transgene.
  • FIG. 1 Chimeric (A) E35S::TDC::nos and (B) UBQ3::TDC::nos constructs.
  • a DNA fragment containing the duplicated enhancer region, promoter, transcription initiation site and 5 ' untranslated region (UTR) from the CaMV 35S RNA region was fused to the 5 ' UTR of the TDC cDNA from plasmid pTDC5.
  • a second DNA fragment containing the promoter, transcription initiation site and 5 ' UTR from the Arabidopsis thaliana UBQ3 gene was fused to the 5 'UTR of the
  • TDC cDNA from plasmid pTDC5.
  • a DNA fragment containing the polyA addition signal from the nopaline synthase gene (nos) is responsible for transcript maturation at the 3 ' end in both transgenes.
  • the present inventors have su ⁇ risingly discovered (as is demonstrated in the Examples, infra) that enhanced TDC expression can confer on plants resistance to a broad spectrum of both bacterial, fungal, and nematode phytopathogens.
  • the present invention comprises methods and nucleic acid constructs for enhancing resistance in plants to phytopathogenic bacteria, fungi, and nematodes by transforming plant cells with the gene coding for tryptophan decarboxylase (TDC).
  • TDC tryptophan decarboxylase
  • the invention is not limited by any theory of action, we believe that enhanced TDC expression results in enhanced phytopathogenic resistance through increased levels of tiyptamine and/or alkaloids produced therefrom.
  • the invention further comprises transgenic plant tissue thereby produced.
  • the invention provides nucleic acid constructs comprising the TDC gene. Any plant TDC gene can be used. Upon transformation of plant cells, these constructs are useful for conferring enhanced fungal, bacterial, and/or nematode resistance to a wide variety of plants and against a broad spectrum of phytopathogenic fungi, bacteria, and nematodes.
  • the invention provides nucleic acid constructs comprising an AS (preferably AS ⁇ l) and a TDC transgene. Any plant AS gene can be used.
  • Co-introduction of constitutively- expressed AS (preferably AS ⁇ l) and TDC transgenes should provide increased tryptophan levels for immediate conversion into tryptamine.
  • AS constitutively- expressed transgenes
  • a single plasmid harboring both constitutively-expressed transgenes can be viewed as portable expression cassette for increasing tryptamine levels in virtually any plant.
  • an AS transgene could be used by itself.
  • the nucleic acid constructs according to this aspect of the invention will further comprise targeting regions at the 3' and 5' ends, which regions target the constructs according to the invention to the plant nucleus or plastid.
  • any plant promoter can be operatively linked to the TDC and/or AS ⁇ l genes.
  • the constructs according to this aspect of the invention will preferably be operatively linked to the UBQ3, UBQIO, CaMV 35S RNA, or the enhanced version of the CaMV 35S RNA (E35S) promoter.
  • the constructs further comprise a pUC-based vector containing the 3 ' flanking region of the nopaline synthase gene (nos) from Agrobacterium tumefaciens.
  • one or both of the transgenes can be fused and thereby operationally linked to tissue-specific promoters.
  • tissue-specific promoters for example, in petunia, one or both of the transgenes can be fused to petal-specific promoters to confer resistance to infection by Botrytis cinerea.
  • Constructs according to this aspect of the invention can also comprise a selectable marker gene, expression of which by the transformed cell enables one to identify and isolate the transformed cell or cells from amongst other cells. Any plant selectable marker gene known in the art can be used in the present invention.
  • the selectable marker gene is the nptll (neomycin phosphotransferase II) or hph (hygromycin phosphotransferase) gene.
  • Cells expressing these preferred selectable marker genes are resistant to kanamycin (for nuclear nptll transformation) and hygromycin (for nuclear transformation) or glyphosate (for plastid hph transformation) and can be selected for by exposing cells subject to transformation (by, e.g., biolistic delivery) to media containing the minimum level of kanamycin, hygromycin, or glyphosate that kill untransformed cells.
  • the agent to which transformed cells are subject for selection pu ⁇ oses should correspond to the selectable marker gene employed in the transformation.
  • the sequence and structure of the constituent elements of the nucleic acid constructs according to this aspect of the invention are publicly available, and constructs according to this aspect of the invention can be made by routine, art recognized techniques. Exemplary methods are described, e.g., in Example 1, infra.
  • the invention provides methods for enhancing the resistance of plants to phytopathogenic fungi, bacteria, and nematodes.
  • the method comprises transforming plant tissue with a construct according to the first aspect of the invention.
  • the two genes when co-transformation with both the TDC and AS ⁇ l genes is desired, can be on separate expression vectors and co-transformed simultaneously or sequentially. Transformation can be accomplished in either the nucleus or the plastid, as determined by the targeting regions of the nucleic acid construct. Details of plastid transformation can be found, e.g., in co-pending international application PCT/US98/**** (WO 99/*****) ? entitled, "Improved Plastid Transformation Of Higher Plants And Production Of Transgenic Plants With Herbicide Resistance," filed July 23, 1998, and U.S. Application Serial No. 08/899,061, filed July 23, 1997. Any of the numerous methods for transformation can be used, e.g., Agrobacterium (for nuclear transformation), PEG treatment, electroporation, and biolistic delivery. Preferably, biolistic delivery is employed.
  • the invention provides transgenic plant tissue that expresses the TDC gene and/or the AS ⁇ l gene.
  • plant tissue includes a plant cell or cells, multicellular plant tissue, and whole plants.
  • Transgenic plants according to this aspect of the invention can be made according to the second aspect of the invention using nucleic acid constructs according to the first aspect of the invention.
  • cells e.g., cell suspensions or calli
  • plant tissue samples e.g., leaf or other plant parts
  • TDC- and/or AS-containing constructs To increase tryptamine production throughout the entire plant, the TDC gene was preferably placed under the control of two very active, constitutively expressed promoters.
  • the CaMV 35S RNA promoter from the CaMV genome is a very well-characterized promoter for expression of transgenes in both dicotyledonous and monocotyledonous plants.
  • the enhanced version (Kay et al, (1987) Science 236, 1299-1302,) of the CaMV 35S RNA promoter (E35S) was preferably used.
  • a second promoter, UBQ3, is derived from Arabidopsis thaliana and normally directs expression of a member of the polyubiquitin gene family. The present inventors have determined that this promoter directs high levels of reporter gene expression throughout the entire plant in transgenic petunias.
  • Both promoters were moved into a pUC -based vector already containing the 3 ' flanking region of the nopaline synthase gene (nos) from Agrobacterium tumefaciens.
  • This DNA sequence element possesses the recognition site for polyA addition to the transcript.
  • Also already resident on this plasmid was a multi-cloning site region containing a number of unique restriction enzyme sites for insertion of additional DNA sequence elements.
  • the CaMV 35S and UBQ3 promoters were moved into this plasmid (while maintaining a number of unique restriction sites between the promoter and the nos 3' sequence element) to create plasmids pSAN14 and pSAN151, respectively.
  • the TDC gene was originally cloned from Catharanthus roseus, or vinca (De Luca et al., (1989), supra.
  • a 1.75 kbp fragment containing the full-length cDNA was cloned from a cDNA library by immunodetection methods.
  • the TDC cDNA contains an open reading frame coding for a protein of 500 amino acids, corresponding to a molecular mass of -56 kDa.
  • the cDNA from plasmid pTDCS (De Luca et al., 1989, supra) was removed by digestion with Pst I and Xho 1, the single-strand overhangs at each end removed by treatment with T4 DNA polymerase, and cloned into the Sma I sites of plasmids ⁇ SAN14 and pSAN151 to create plasmids pSAN213 and pSAN247, respectively ( Figure 1).
  • TDC-containing plasmids were to be co-bombarded with a second plasmid containing a plant selectable marker gene like nptll (neomycin phosphotransferase 11) or hph (hygromycin phosphotransferase), no marker gene was added to the TDC-containing plasmid.
  • a plant selectable marker gene like nptll (neomycin phosphotransferase 11) or hph (hygromycin phosphotransferase
  • Construct pSAN368 contains the AS ⁇ l gene driven by the UBQl 0 promoter and, constructs pSAN369 and pSAN310 contained in addition to the AS ⁇ l gene the TDC gene driven by the UBQ3 pormoter.
  • TDC transgenes were introduced into petunia by particle bombardment. Briefly, two plasmids, one containing the TDC transgene and the second containing an nptll transgene, were co- precipitated in equivalent amounts onto - 1 ⁇ m M-10 tungsten particles. The DNA coated particles were then bombarded into petunia leaf explants that had been placed on a nutrient agar media. After two successive bombardments, the leaf explants were allowed to recover on the nutrient media for four to five days. After recovery, the leaf explants were cut into small pieces and placed onto selective agar media containing kanamycin. Kanamycin-resistant transformed shoots were regenerated and shoots were transferred to fresh media and rooted in the absence of kanamycin.
  • MIC Tryptamine minimum inhibitory concentration
  • a MIC minimum tryptamine concentration required to inhibit all fungal growth after 48 hours, not assayed
  • Phytophthora parasitica were inhibited by 0.25 mg/ml tryptamine. Germinated spores from both Phytophthora isolates were sensitive to 0.25-0.50 mg/ml tryptamine. Similar results were observed for Thielaviopsis basicola (germinated and non-germinated spores). Regarding the Fusarium species, non-germinated spores from F. graminearum were somewhat sensitive to tryptamine while those from F. solani were considered insensitive. However, germinated spores from F. solani were sensitive. Also, growth from nongerminated spores of Botrytis cinerea were inhibited by 0.50 mg/ml tryptamine. Rhizoctonia solani mycelial fragments were unaffected by 1 mg/ml tryptamine. In general, nearly all the fungi exhibited some level of sensitivity to treatment with tryptamine.
  • tryptamine's mode of action was fungicidal or fungistatic.
  • Botrytis cinerea spores were exposed to toxic levels of tryptamine for various times, then diluted to sub-lethal concentrations to permit growth. If the spores now germinated and grew, then tryptamine's effect was considered to be fungistatic. If no growth was observed, the effect was concluded to be fungicidal.
  • Botrytis spores maintained in 0.50 mg/ml tryptamine throughout the entire experiment showed essentially no growth while all growth was inhibited at 1 mg/ml.
  • Botrytis spores exposed to 1 mg/ml tryptamine for 22 h showed no growth, but when diluted to 0.25 mg/ml, germinated and grew normally over the next 48 h.
  • spores exposed to 2 mg/ml for 22 h showed no growth, but when diluted to 0.5 mg/ml, germinated and grew, albeit relatively poorly.
  • Tryptamine acts primarily as a fungistatic agent against Botrytis cinerea rather than a fungicidal one
  • MIC Tryptamine minimum inhibitory concentration
  • MIC minimum tryptamine concentration required to inhibit all bacterial growth after 24 hrs.
  • Petunia line PE-261 contains the TDC gene under control of the E35S promoter while lines PE-310 and PE-312 contain the TDC gene under control of the UBQ3 promoter.
  • Tryptamine levels were measured in the leaf tissue of both in vitro and greenhouse-grown plants.
  • Leaf tissue from in vitro and greenhouse plants and petal tissue from greenhouse plants (all -10-20 mgs fresh weight) were excised and homogenized in 0.2 ml cold 50 mM Na 3 PO 4 , pH 7.4 buffer. Cell debris was removed by centrifugation at 10,000 x g for 5 min at 4 °C.
  • the tryptamine levels ranged from 141-310 ⁇ g/gfw.
  • the levels decreased approximately 4-fold for all three lines to 42-80 ⁇ g/gfw. It is especially worth noting that this decrease can most likely be attributed to a reduction in the level of available tryptophan in the cell.
  • the levels of tryptophan in the leaves of the untransformed V26 control and each of the transgenic lines dropped -4-fold when plants were transferred to the greenhouse. In all three transgenic lines, the ratio of tryptamine to tryptophan content in the cells remained unchanged.
  • Transgenic TDC-expressing Petunia resistance to powdery mildew Greenhouse-grown petunia lines PE-261 , PE-310, PE-312 and an untransformed V26 control were inoculated on their leaf surface with a 5 ⁇ l droplet containing 10 3 powdery mildew spores. The third leaf (from the top) on each of five shoots of a single plant was inoculated. Each line was represented by four plants (for a total of 20 inoculation sites). Disease progression was monitored for approximately two weeks by recording the percentage of inoculated sites infected and measuring the diameter of the fungal colony with calipers to calculate their size (area). The results are displayed in Table 6.
  • V26 control and PE-261 lines showed equal susceptibility to infection by Botrytis.
  • lines PE-310 and PE-312 still exhibited greatly reduced rates of infection by Botrytis.
  • PE-310 flowers still showed only a small number of isolated lesions. Disease symptoms were only slightly more advanced in PE312 flowers as the lesions were more numerous and larger.
  • leaf disks of transgenic petunia lines were inoculated with the foliar nematode Aphelenchoides fragariae. Briefly, leaf disks (2.1 cm diameter) were cut from surface sterilized greenhouse grown leaves of the transgenic V26 petunia lines (PE-310 and PE-312) and the non-transgenic control. Disks were placed onto wet filter paper in a multi-well dish (1 disk/well) and then inoculated with a drop containing 50 A.fragariae nematodes that had been raised on a sterile tobacco callus culture.
  • Inoculated disks were incubated for eighteen days at room temperature and then the number of nematodes per well was quantified. Although, there was an increase in nematode population in each well, the two transgenic lines (PE- 310, PE-312) showed only a slight increase (from 50 to 74 or 67 respectively) while the non- transgenic control increased four fold (from 50 to 194).
  • TDC transgenic plants of any species overexpressing the TDC and/or AS gene should be resistant to nematodes, as long as the target tissue has adequate amounts of tryptamine. In the plants we have tested, tryptophan and tryptamine levels are low in the roots.
  • Botrytis cinerea resistance in other transgenic plant species Several other plant species (poinsettia cv. Angelika, geranium Designer Scarlet, lisianthus and another bedding plant) were transformed with the TDC gene. A measurable increase in tryptamine was found in transgenic poinsettia and geranium lines. Transgenic poinsettia lines demonstrated resistance to Botrytis cinerea in a leaf disk assay. Briefly, twelve leaf disks (8 mm in diameter) from each tissue culture-maintained transformed lines (and an untransformed control) were punched out with a cork borer and placed onto moistened Whatman 3M paper inside a sterile plastic bioassay dish.
  • a freshly-prepared suspension of Botrytis spores (10 3 spores in 2.5 ⁇ l) was then pipetted onto the leaf disk surface.
  • the humidity chamber was sealed and the leaf disks left at 20°C to permit disease development.
  • timeline is species-dependent
  • disease progression was monitored and recorded as percentage of leaf disks infected.
  • Transgenic geranium lines demonstrated resistance to Botrytis cinerea infection when flowers were inoculated.
  • transgenic plant species we observed increased tryptophan and tryptamine concentration when the AS/TDC combination was used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne des produits de recombinaison d'acides nucléiques et des procédés utiles pour la production de plantes transgéniques présentant une résistance accrue à des champignons, des bactéries et/ou des nématodes, cette résistance accrue provenant de l'expression accrue d'un produit de recombinaison de gène de tryptophane décarboxylase (TDC).
PCT/US1998/016033 1997-07-31 1998-07-31 Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures WO1999006581A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000505321A JP2001512028A (ja) 1997-07-31 1998-07-31 穀物改良のためのｔｄｃ遺伝子を用いたトランスジェニック植物
EP98938251A EP0994957A1 (fr) 1997-07-31 1998-07-31 Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures
CA002298882A CA2298882A1 (fr) 1997-07-31 1998-07-31 Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures
AU86821/98A AU8682198A (en) 1997-07-31 1998-07-31 Transgenic plants using the tdc gene for crop improvement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5431697P 1997-07-31 1997-07-31
US60/054,316 1997-07-31

Publications (1)

Publication Number Publication Date
WO1999006581A1 true WO1999006581A1 (fr) 1999-02-11

Family

ID=21990223

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/016033 WO1999006581A1 (fr) 1997-07-31 1998-07-31 Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures

Country Status (5)

Country Link
EP (1) EP0994957A1 (fr)
JP (1) JP2001512028A (fr)
AU (1) AU8682198A (fr)
CA (1) CA2298882A1 (fr)
WO (1) WO1999006581A1 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055325A2 (fr) * 1999-03-18 2000-09-21 The University Of Chicago Compositions de chromosomes vegetaux et methodes
WO2002090497A2 (fr) * 2001-05-04 2002-11-14 Renessen Llc Plantes transgeniques a contenu eleve en tryptophane
EP1445321A1 (fr) 2002-12-18 2004-08-11 Monsanto Technology LLC Promoteur spécifique de l'embryon de mais et procédés d'utilisation correspondants
US6972197B1 (en) 1999-03-18 2005-12-06 The University Of Chicago Plant chromosome compositions and methods
WO2006089950A2 (fr) 2005-02-26 2006-08-31 Basf Plant Science Gmbh Cassettes d'expression destinees a une expression preferentielle de semences chez des plantes
WO2006120197A2 (fr) 2005-05-10 2006-11-16 Basf Plant Science Gmbh Cassettes d'expression pour l'expression preferentielle de semence dans des plantes
WO2006133983A1 (fr) 2005-04-19 2006-12-21 Basf Plant Science Gmbh Expression specifique de l'albumen farineux et/ou de l'embryon en germination dans des plantes monocotyledonees
WO2008099013A1 (fr) 2007-02-16 2008-08-21 Basf Plant Science Gmbh Séquences d'acides nucléiques pour la régulation de l'expression spécifique de l'embryon dans des plantes monocotyles
EP2116606A1 (fr) 2003-03-28 2009-11-11 Monsanto Technology, LLC Nouveaux promoteurs végétaux pour une utilisation pendant le développement précoce des graines
EP2216405A1 (fr) 2002-05-03 2010-08-11 Monsanto Technology LLC Promoteurs USP spécifiques de sémences pour l'expression de gènes dans des plantes
WO2010118477A1 (fr) 2009-04-17 2010-10-21 Molecular Plant Breeding Nominees Ltd Promoteur végétal apte à agir dans l'endosperme et ses utilisations
WO2011003901A1 (fr) 2009-07-10 2011-01-13 Basf Plant Science Company Gmbh Cassettes d'expression pour l'expression spécifiquement dans l'endosperme dans des plantes
WO2011067712A1 (fr) 2009-12-03 2011-06-09 Basf Plant Science Company Gmbh Cassette d'expression pour expression spécifique de l'embryon dans des plantes
WO2011114279A1 (fr) * 2010-03-18 2011-09-22 Basf Plant Science Company Gmbh Plantes possédant des caractéristiques favorisant le rendement, et leur procédé d'obtention
US8158851B2 (en) 2002-05-03 2012-04-17 Monsanto Technology Llc Transgenic high tryptophan plants
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2184363B1 (fr) * 2003-11-10 2013-08-28 Icon Genetics GmbH Système d'expression dans les plantes dérivé d'un virus a ARN
JP2013036889A (ja) * 2011-08-09 2013-02-21 Hamamatsu Photonics Kk 植物体の病原菌感染診断装置及び植物体の病原菌感染診断方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010073A1 (fr) * 1989-02-24 1990-09-07 Majesty (Her) In Right Of Canada As Represented By The National Research Council Of Canada Gene d'origine vegetale de tryptophane decarboxylase produisant de la tryptamine
DE4138209A1 (de) * 1991-11-21 1993-05-27 Karlheinz Dr Seifert Holzschutzmittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010073A1 (fr) * 1989-02-24 1990-09-07 Majesty (Her) In Right Of Canada As Represented By The National Research Council Of Canada Gene d'origine vegetale de tryptophane decarboxylase produisant de la tryptamine
DE4138209A1 (de) * 1991-11-21 1993-05-27 Karlheinz Dr Seifert Holzschutzmittel

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BOHLMANN J ET AL: "PURIFICATION AND CDNA CLONING OF ANTHRANILATE SYNTHASE FROM RUTA GRAVEOLENS, MODES OF EXPRESSION AND PROPERTIES OF NATIVE AND RECOMBINANT ENZYMES", PLANT JOURNAL, vol. 7, no. 3, 1995, pages 491 - 501, XP002032323 *
CHAVADEJ, S., ET AL.: "redirection of tryptophan leads to production of low indole glucosinolate canola", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 91, March 1994 (1994-03-01), pages 2166 - 2170, XP002001305 *
DE LUCA, V., ET AL.: "molecular cloning and analysis of cDNA encoding a plant tryptophan decarboxylase: comparison with animal dopa decarboxylases", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 86, April 1989 (1989-04-01), pages 2582 - 2586, XP002085257 *
NIYOGI K K ET AL: "TWO ANTHRANILATE SYNTHASE GENES IN ARABIDOPSIS: DEFENSE-RELATED REGULATION OF THE TRYPTOPHAN PATHWAY", PLANT CELL, vol. 4, June 1992 (1992-06-01), pages 721 - 733, XP002032324 *
SONGSTAD, D.D., ET AL.: "high levels of tryptamine accumulation in transgenic tobacco expressing tryptophan decarboxylase", PLANT PHYSIOLOGY, vol. 94, 1990, pages 1410 - 1413, XP002085254 *
THOMAS,J.C., ET AL.: "tryptophan decarboxylase, tryptamine, and reproduction of the whitefly", PLANT PHYSIOLOGY, vol. 109, 1995, pages 717 - 720, XP002085256 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055325A3 (fr) * 1999-03-18 2001-08-23 Univ Chicago Compositions de chromosomes vegetaux et methodes
US6972197B1 (en) 1999-03-18 2005-12-06 The University Of Chicago Plant chromosome compositions and methods
WO2000055325A2 (fr) * 1999-03-18 2000-09-21 The University Of Chicago Compositions de chromosomes vegetaux et methodes
US7217865B2 (en) * 2001-05-04 2007-05-15 Monsanto Technology Llc Transgenic high tryptophan plants
WO2002090497A2 (fr) * 2001-05-04 2002-11-14 Renessen Llc Plantes transgeniques a contenu eleve en tryptophane
CN1719971B (zh) * 2001-05-04 2011-04-13 雷尼森有限责任公司 转基因高色氨酸植物细胞
WO2002090497A3 (fr) * 2001-05-04 2005-04-28 Renessen Llc Plantes transgeniques a contenu eleve en tryptophane
US8158851B2 (en) 2002-05-03 2012-04-17 Monsanto Technology Llc Transgenic high tryptophan plants
EP2216405A1 (fr) 2002-05-03 2010-08-11 Monsanto Technology LLC Promoteurs USP spécifiques de sémences pour l'expression de gènes dans des plantes
EP1445321A1 (fr) 2002-12-18 2004-08-11 Monsanto Technology LLC Promoteur spécifique de l'embryon de mais et procédés d'utilisation correspondants
EP2116606A1 (fr) 2003-03-28 2009-11-11 Monsanto Technology, LLC Nouveaux promoteurs végétaux pour une utilisation pendant le développement précoce des graines
EP2116607A1 (fr) 2003-03-28 2009-11-11 Monsanto Technology, LLC Nouveaux promoteurs végétaux pour une utilisation pendant le développement précoce des graines
WO2006089950A2 (fr) 2005-02-26 2006-08-31 Basf Plant Science Gmbh Cassettes d'expression destinees a une expression preferentielle de semences chez des plantes
WO2006133983A1 (fr) 2005-04-19 2006-12-21 Basf Plant Science Gmbh Expression specifique de l'albumen farineux et/ou de l'embryon en germination dans des plantes monocotyledonees
WO2006120197A2 (fr) 2005-05-10 2006-11-16 Basf Plant Science Gmbh Cassettes d'expression pour l'expression preferentielle de semence dans des plantes
WO2008099013A1 (fr) 2007-02-16 2008-08-21 Basf Plant Science Gmbh Séquences d'acides nucléiques pour la régulation de l'expression spécifique de l'embryon dans des plantes monocotyles
WO2010118477A1 (fr) 2009-04-17 2010-10-21 Molecular Plant Breeding Nominees Ltd Promoteur végétal apte à agir dans l'endosperme et ses utilisations
WO2011003901A1 (fr) 2009-07-10 2011-01-13 Basf Plant Science Company Gmbh Cassettes d'expression pour l'expression spécifiquement dans l'endosperme dans des plantes
US9096909B2 (en) 2009-07-23 2015-08-04 Chromatin, Inc. Sorghum centromere sequences and minichromosomes
WO2011067712A1 (fr) 2009-12-03 2011-06-09 Basf Plant Science Company Gmbh Cassette d'expression pour expression spécifique de l'embryon dans des plantes
EP3002332A2 (fr) 2009-12-03 2016-04-06 BASF Plant Science Company GmbH Cassettes d'expression pour expression spécifique à des embryons dans des plantes
WO2011114279A1 (fr) * 2010-03-18 2011-09-22 Basf Plant Science Company Gmbh Plantes possédant des caractéristiques favorisant le rendement, et leur procédé d'obtention
CN103037682A (zh) * 2010-03-18 2013-04-10 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法

Also Published As

Publication number Publication date
AU8682198A (en) 1999-02-22
JP2001512028A (ja) 2001-08-21
CA2298882A1 (fr) 1999-02-11
EP0994957A1 (fr) 2000-04-26

Similar Documents

Publication Publication Date Title
US6215048B1 (en) Nucleic acid sequences encoding an antifungal polypeptide, aly AFP from alyssum and methods for their use
EP0994957A1 (fr) Plantes transgeniques employant le gene de tdc (tryptophane decarboxylase) en vue d'une amelioration des cultures
US5530187A (en) Transgenic plants containing multiple disease resistance genes
WO2000011178A2 (fr) Proteine antifongique provenant de la fetuque elevee et son utilisation dans la lutte contre les parasites phytosanitaires
US8445747B2 (en) Plant responses
KR20000029948A (ko) 식물병원성진균에대해억제활성을갖는펩타이드
JP2001508288A (ja) 植物防御法
JP2002523103A (ja) 非宿主植物病害抵抗性遺伝子の新しい同定方法
Chen et al. Overexpression of glucanase gene and defensin gene in transgenic tomato enhances resistance to Ralstonia solanacearum
US20150203866A1 (en) Methods and compositions for plant pest control
CA2333433A1 (fr) Genes de la voie de l'acide salicylique et leur utilisation pour induire la resistance chez les vegetaux
EP0990033A1 (fr) Expression de genes de peptides antimicrobiens dans des plantes, et leur utilisation pour creer une resistance a de multiples pathogenes de plantes
US8067542B1 (en) Amino acid sequence variant alfalfa antifungal protein and its use in plant disease control
US7041815B2 (en) Sporamin promoter and uses thereof
US7105725B2 (en) Pathogen resistant transgenic plants expressing CEMA or CEMA-related peptides
WO1999006579A2 (fr) Inhibition de l'action non desiree d'hormones dans des plantes
EP2184351A1 (fr) Synthase caryophyllène codant pour les polynucléotides et ses utilisations
Mørk Disease resistance in ornamental plants:-Transformation of Symphyotrichum Novi-Belgii with powdery mildew resistance genes
US10316327B2 (en) Genetically modified plants that are insect-resistant and/or rot resistant
US20030040102A1 (en) Feedback-regulated expression system and uses thereof
KR20130005986A (ko) 벼도열병 저항성 ＯｓＡＢＰ57 유전자 및 이의 용도
ZA200005115B (en) Salicylic acid pathway genes and their use for the induction of resistance in plants.
MXPA98008018A (en) Antimictic polypeptide and methods to control fitopatoge fungi

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2298882

Country of ref document: CA

Ref country code: CA

Ref document number: 2298882

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1998938251

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 86821/98

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998938251

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998938251

Country of ref document: EP